DOJ Cracks Down on Healthcare Fraud, Corporate Enforcement Shifts Focus

The most significant news out of the Department of Justice this week is the launch of a new joint working group with the Department of Health and Human Services to crack down on healthcare fraud. Announced on July 2nd, this DOJ-HHS False Claims Act Working Group is set to ramp up investigations and use advanced data analytics to identify new fraud patterns in the healthcare sector. Last year alone, DOJ recovered more than $2.9 billion from False Claims Act cases, and this intensified focus signals that enforcement is only accelerating. Deputy Assistant Attorney General Brenna Jenny, who’s co-leading the group, says it will leverage cross-agency collaboration and novel legal strategies to ensure the most serious and provable complaints are prosecuted, aiming to “combat and deter healthcare fraud” more efficiently. This move comes amid broader DOJ policy shifts on white-collar and corporate enforcement. In a major address this May, Criminal Division head Matthew Galeotti said the department is seeking a new balance: robustly prosecuting corporate wrongdoing without placing unnecessary burdens on American businesses. The DOJ is emphasizing alternatives to criminal prosecution for corporations, encouraging cooperation and self-disclosure, and aiming to avoid stifling innovation through overbroad enforcement. Galeotti stated, “We must root out insidious conduct, but we can’t let enforcement punish legitimate risk-taking or hinder economic growth.” The DOJ will now prioritize focus, fairness, and efficiency—prosecuting the worst offenses quickly and using heavy-handed interventions like corporate monitors only when absolutely necessary. There’s also big news in data security. July marks the start of DOJ enforcement for its new Bulk Sensitive Data Rule, first issued this spring. As outlined by Deputy Attorney General Todd Blanche, these new rules prohibit bulk data transfers to foreign adversaries—making it much harder for countries of concern to access Americans’ personal or government-related data. The DOJ describes these threats as an “unusual and extraordinary” risk to national security, and enforcement aims to close the loopholes that foreign entities could exploit by simply buying or demanding Americans’ data. These developments have real-world impacts. For citizens, tighter healthcare fraud controls help protect both taxpayer money and patient safety. For businesses, particularly healthcare and tech firms, the DOJ’s shift to encourage voluntary cooperation and streamline investigations could mean fewer burdens for those acting in good faith—while increasing the risk for those trying to skirt the law. State and local governments may see more federal involvement, especially as the DOJ signals it will intervene in local cases where it perceives “rule of law deficiencies.” Internationally, the new data security measures could complicate business for foreign firms and impact U.S. allies and adversaries alike, as data flows are more tightly regulate This content was created in partnership and with the help of Artificial Intelligence AI.